Erste Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

Erste Asset Management’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.83M	Sell	20,100 -1,800	-8%	-$530K	0.05%	286
2026 Q1	$6.22M	Hold	21,900	–	–	0.06%	240
2025 Q4	$6.8M	Hold	21,900	–	–	0.06%	233
2025 Q3	$7.29M	Buy	21,900 +1,400	+7%	+$425K	0.07%	204
2025 Q2	$4.94M	Hold	20,500	–	–	0.04%	277
2025 Q1	$5.48M	Hold	20,500	–	–	0.07%	217
2024 Q4	$3.73M	Hold	20,500	–	–	0.05%	265
2024 Q3	$4.48M	Buy	20,500 +7,900	+63%	+$1.42M	0.05%	253
2024 Q2	$1.83M	Hold	12,600	–	–	0.02%	313
2024 Q1	$1.95M	Hold	12,600	–	–	0.03%	305
2023 Q4	$2.26M	Hold	12,600	–	–	0.03%	285
2023 Q3	$2.32M	Hold	12,600	–	–	0.04%	263
2023 Q2	$2.25M	Hold	12,600	–	–	0.04%	275
2023 Q1	$2.75M	Buy	12,600 +1,600	+15%	+$384K	0.05%	264
2022 Q4	$2.46M	Hold	11,000	–	–	0.05%	262
2022 Q3	$1.5M	Hold	11,000	–	–	0.03%	311
2022 Q2	$1.79M	Hold	11,000	–	–	0.04%	292
2022 Q1	$2.27M	Sell	11,000 -1,500	-12%	-$319K	0.04%	279
2021 Q4	$3.26M	Hold	12,500	–	–	0.06%	255
2021 Q3	$4.52M	Hold	12,500	–	–	0.09%	208
2021 Q2	$4.46M	Hold	12,500	–	–	0.09%	216
2021 Q1	$4.16M	Hold	12,500	–	–	0.1%	205
2020 Q4	$3.06M	Sell	12,500 -500	-4%	-$138K	0.08%	218
2020 Q3	$3.66M	Sell	13,000 -14,600	-53%	-$3.43M	0.12%	181
2020 Q2	$5.22M	Hold	27,600	–	–	0.21%	128
2020 Q1	$3.46M	Hold	27,600	–	–	0.2%	130
2019 Q4	$4.61M	Hold	27,600	–	–	0.2%	121
2019 Q3	$3.36M	Hold	27,600	–	–	0.18%	132
2019 Q2	$3.47M	Hold	27,600	–	–	0.18%	128
2019 Q1	$3.49M	Hold	27,600	–	–	0.2%	128
2018 Q4	$3.8M	Buy	+27,600	New	+$3.66M	0.26%	106

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Erste Asset Management's ONC Position: Q2 2026 in Review

Erste Asset Management reduced its BeOne Medicines Ltd (ONC) stake by 8.2% in Q2 2026, selling an estimated $530K and leaving 20,100 shares worth $5.83M. The position accounts for 0.05% of the portfolio, ranked #286.

Erste Asset Management first reported a position in ONC in Q4 2018 and has held it in 31 quarters since. The position peaked at $7.29M in Q3 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Erste Asset Management held 20,100 shares of BeOne Medicines Ltd worth $5.83M as of Q2 2026.
Erste Asset Management sold 1,800 BeOne Medicines Ltd shares in Q2 2026, an estimated $530K.
BeOne Medicines Ltd made up 0.05% of Erste Asset Management's portfolio in Q2 2026, its #286 holding.
Erste Asset Management first reported a position in BeOne Medicines Ltd in Q4 2018 and has held it in 31 quarters since.
Erste Asset Management's BeOne Medicines Ltd position peaked at $7.29M in Q3 2025.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.